Praxis Precision Medicines (PRAX) Operating Margin: 2023-2025
Historic Operating Margin for Praxis Precision Medicines (PRAX) over the last 3 years, with Sep 2025 value amounting to -1,770.82%.
- Praxis Precision Medicines' Operating Margin rose 1704871.00% to -1,770.82% in Q3 2025 from the same period last year, while for Sep 2025 it was -1,316.76%, marking a year-over-year increase of 890225.00%. This contributed to the annual value of -2,340.29% for FY2024, which is 282412.00% up from last year.
- According to the latest figures from Q3 2025, Praxis Precision Medicines' Operating Margin is -1,770.82%, which was down 15.00% from -1,539.82% recorded in Q2 2025.
- In the past 5 years, Praxis Precision Medicines' Operating Margin ranged from a high of -856.97% in Q4 2024 and a low of -18,819.54% during Q3 2024.
- Its 3-year average for Operating Margin is -5,953.34%, with a median of -5,399.22% in 2023.
- In the last 5 years, Praxis Precision Medicines' Operating Margin slumped by 1,336,740bps in 2024 and then soared by 1,704,871bps in 2025.
- Quarterly analysis of 3 years shows Praxis Precision Medicines' Operating Margin stood at -5,399.22% in 2023, then surged by 454,225bps to -856.97% in 2024, then spiked by 1,704,871bps to -1,770.82% in 2025.
- Its last three reported values are -1,770.82% in Q3 2025, -1,539.82% for Q2 2025, and -1,375.70% during Q1 2025.